Impact of Renal Function on the Pharmacokinetics and Safety of Ceftolozane-Tazobactam

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02151-13
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted With Acute Pulmonary Exacerbation

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous Hemofiltration

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

The Effect of Renal Impairment on the Pharmacokinetics and Safety of Itacitinib

Journal of Clinical Pharmacology
Pharmacology
2020English

Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects With Renal Function Impairment

Antiviral Therapy
Infectious DiseasesPharmacology
2015English

In Vitro Susceptibility of Ceftolozane-Tazobactam Against Burkholderia Pseudomallei

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

The Efficacy and Safety of Tazobactam/Ceftolozane in Combination With Metronidazole in Japanese Patients With Complicated Intra-Abdominal Infections

Journal of Infection and Chemotherapy
Infectious DiseasesMicrobiologyPharmacology
2019English

Effect of Age and Renal Function on Cefonicid Pharmacokinetics.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1989English

The Pharmacokinetics and Safety of Darapladib in Subjects With Severe Renal Impairment

British Journal of Clinical Pharmacology
Pharmacology
2015English

Ceftolozane/Tazobactam Population Pharmacokinetics and Dose Selection for Further Clinical Evaluation in Pediatric Patients With Complicated Urinary Tract or Complicated Intraabdominal Infections

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy